Matches in Wikidata for { <http://www.wikidata.org/entity/Q79187796> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q79187796 description "article scientifique publié en 2006" @default.
- Q79187796 description "artículu científicu espublizáu en setiembre de 2006" @default.
- Q79187796 description "im September 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q79187796 description "scientific article published on 03 September 2006" @default.
- Q79187796 description "wetenschappelijk artikel" @default.
- Q79187796 description "наукова стаття, опублікована у вересні 2006" @default.
- Q79187796 name "Imatinib mesylate (Gleevec) protects against streptozotocin-induced diabetes and islet cell death in vitro" @default.
- Q79187796 name "Imatinib mesylate (Gleevec) protects against streptozotocin-induced diabetes and islet cell death in vitro" @default.
- Q79187796 type Item @default.
- Q79187796 label "Imatinib mesylate (Gleevec) protects against streptozotocin-induced diabetes and islet cell death in vitro" @default.
- Q79187796 label "Imatinib mesylate (Gleevec) protects against streptozotocin-induced diabetes and islet cell death in vitro" @default.
- Q79187796 prefLabel "Imatinib mesylate (Gleevec) protects against streptozotocin-induced diabetes and islet cell death in vitro" @default.
- Q79187796 prefLabel "Imatinib mesylate (Gleevec) protects against streptozotocin-induced diabetes and islet cell death in vitro" @default.
- Q79187796 P1433 Q79187796-AE061145-897C-4BB0-9BF1-17A235905C8C @default.
- Q79187796 P1476 Q79187796-DE83EF6B-BC1C-4EB5-9857-8FE125A216CC @default.
- Q79187796 P2093 Q79187796-0A047A8E-B0FB-46FA-9A7B-EE1E7440CAB1 @default.
- Q79187796 P2093 Q79187796-15A5A0D3-2640-494F-8B4B-0E2D8AC56D5E @default.
- Q79187796 P2093 Q79187796-92956277-A7CC-40BC-B1F9-F7467A16777C @default.
- Q79187796 P2093 Q79187796-FC1DCC8E-408A-4228-BA1E-E2A01C987AB7 @default.
- Q79187796 P304 Q79187796-CD3CA291-1753-4B38-AE29-32923CA59606 @default.
- Q79187796 P31 Q79187796-21D1BCAD-2043-4C5F-A0CE-7C9C851409D5 @default.
- Q79187796 P356 Q79187796-CF12B104-C74B-4B79-A219-7DA961ACC124 @default.
- Q79187796 P433 Q79187796-27BEE740-B3D4-4336-9951-CADA7046C64C @default.
- Q79187796 P478 Q79187796-78CB0DBA-E866-4A5F-B090-AE929F6AD94E @default.
- Q79187796 P577 Q79187796-7456A821-A655-4960-B5B0-7B153E95C952 @default.
- Q79187796 P698 Q79187796-80BF6180-7605-4DA5-9059-6F51C03F01B7 @default.
- Q79187796 P921 Q79187796-83FB6E61-BBD7-45D3-B591-FB7A86499361 @default.
- Q79187796 P921 Q79187796-D9EE5C71-1FC2-43E6-B1F9-061037CC9436 @default.
- Q79187796 P356 J.CELLBI.2006.08.006 @default.
- Q79187796 P698 17020808 @default.
- Q79187796 P1433 Q1254690 @default.
- Q79187796 P1476 "Imatinib mesylate (Gleevec) protects against streptozotocin-induced diabetes and islet cell death in vitro" @default.
- Q79187796 P2093 "Natalia Makeeva" @default.
- Q79187796 P2093 "Nils Welsh" @default.
- Q79187796 P2093 "Robert Hägerkvist" @default.
- Q79187796 P2093 "Stephen Elliman" @default.
- Q79187796 P304 "1013-1017" @default.
- Q79187796 P31 Q13442814 @default.
- Q79187796 P356 "10.1016/J.CELLBI.2006.08.006" @default.
- Q79187796 P433 "12" @default.
- Q79187796 P478 "30" @default.
- Q79187796 P577 "2006-09-03T00:00:00Z" @default.
- Q79187796 P698 "17020808" @default.
- Q79187796 P921 Q177094 @default.
- Q79187796 P921 Q2383867 @default.